InsidersTradesSigma
Enzymatica AB (publ): management transactions · Finland · FIN-FSA
FI:enzymatica-ab-publSE0003943620FI·FIN-FSAMcap 602M€Healthcare
Browse the full insider trade history of Enzymatica AB (publ), a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Enzymatica AB (publ) has published 6 insider filings. Market capitalisation: €602m. The latest transaction was disclosed on 1 April 2026 — Sale. Among the most active insiders: Anna Söderlund. All data is free.
6
Insider Decl.
0
Thresholds
€61,686
5 ops.
Buy Volume
€10,959
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.48 €
Analyst consensus
Income statement
Revenue53.9 M€
Gross profit33.1 M€61% margin
Net income−51.9 M€-89.2% margin
Valuation
P/Book5.4x
Beta-0.37
Balance sheet & cash
Market cap602.0 M€
Total debt1.0 M€
Free Cash Flow−41.2 M€
Debt / Equity1%
Profitability & ownership
ROE-35.2%
ROA-19.0%
% insiders69.4%
% institutions4.3%
Last declaration on 1 April 2026
Declarations6 total
Executives●Sale20FIN-FSA
€10,95940,000 shares@ €0.2740.0018% mcap32.1% of flow
Aktie
FI:A003X482-1·
Executives●Purchase14FIN-FSA
€13,52348,000 shares@ €0.28170.0022% mcap36.0% of flow
Aktie
FI:A003M475-1·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase18FIN-FSA
€12,80650,000 shares@ €0.25610.0021% mcap37.5% of flow
Aktie
FI:A003M472-1·
Ideal exit: 7 Dec 2025 (T+270)
Executives●Purchase17FIN-FSA
€10,39640,000 shares@ €0.25990.0017% mcap30.4% of flow
Aktie
FI:A003M250-1·
Ideal exit: 1 Dec 2025 (T+270)
Executives●Purchase18FIN-FSA
€9223,500 shares@ €0.26350.0002% mcap100.0% of flow
Aktie
FI:A003M244-1·
Ideal exit: 1 Dec 2025 (T+270)
Executives●Purchase16FIN-FSA
€24,040100,000 shares@ €0.24040.0040% mcap64.0% of flow
Aktie
FI:A003M153-1·
Ideal exit: 28 Nov 2025 (T+270)
6 of 6 declarations